1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
10qk
10qk
Articles 

Pall Corp. Reports Operating Results (10-Q)

June 11, 2012 | About:

Pall Corp. (NYSE:PLL) filed Quarterly Report for the period ended 2012-04-30.

Pall Corp has a market cap of $6.14 billion; its shares were traded at around $52.34 with a P/E ratio of 17.9 and P/S ratio of 2.2. The dividend yield of Pall Corp stocks is 1.6%. Pall Corp had an annual average earning growth of 9.5% over the past 10 years. GuruFocus rated Pall Corp the business predictability rank of 4.5-star.

Highlight of Business Operations:

Research and development (“R&D”) expenses were $20,780 in the third quarter of fiscal year 2012 compared to $19,308 in the third quarter of fiscal year 2011, an increase of $1,472, or 7.6% ($1,700, or 9% in local currency). The increase in R&D expenses in local currency in the quarter reflects increased spending in the Life Sciences segment partly offset by a decline in the Industrial segment. As a percentage of sales, R&D expenses were 3.2% in the quarter compared to 3.0% in the third quarter of fiscal year 2011. In the nine months, R&D expenses were $60,351 compared to $57,198 in the nine months of fiscal year 2011, an increase of $3,153, or 5.5% as reported and in local currency. The increase in R&D expenses in local currency in the nine months reflects increased spending in Life Sciences partly offset by a decline in Industrial. As a percentage of sales, R&D expenses were 3.1% in the nine months compared to 3.2% in the nine months of fiscal year 2011. For a discussion of R&D expenses by business, refer to the section “Review of Operating Segments” below.

SG&A expenses in the third quarter of fiscal year 2012, increased by $7,290, or 8.7% (an increase of approximately $9,600, or 11% in local currency) compared to the third quarter of fiscal year 2011. In the nine months, SG&A expenses increased by $26,752, or 11.2% (an increase of approximately $25,900, or 11% in local currency) compared to the nine months of fiscal year 2011. Selling expenses increased approximately 1% in the quarter and 7% in the nine months. G&A expenses increased approximately 23% and 18% in the quarter and nine months, respectively. In addition to inflation in payroll and related costs that impacted both selling and G&A expenses, the increase in SG&A (in local currency) in the quarter and nine months principally reflects increased spending related to regional expansion in emerging markets (impacting selling and G&A expenses), including the acquisition in Brazil, incremental costs related to the acquisition of ForteBio (selling and G&A) and information technology related costs as discussed in the Review of Consolidated Results above. SG&A as a percentage of sales increased to 28.7% from 26.9% in the third quarter of fiscal year 2011. The selling and G&A expense components of SG&A as a percentage of sales in the quarter were as follows:

R&D expenses in the third quarter of fiscal year 2012 were $13,512, an increase of $1,349, or 11.1% (approximately $1,500, or 13% in local currency). As a percentage of sales, R&D expenses were 4.2% compared to 3.9% in the third quarter of fiscal year 2011. In the nine months, R&D expenses were $37,196, an increase of $1,940, or 5.5% (approximately $2,000, or 6% in local currency). As a percentage of sales, R&D expenses were 4.0% compared to 4.1% in the nine months of fiscal year 2011.

Segment profit dollars were $75,386, a decrease of $3,499, or 4.4% (approximately $2,300, or 3% in local currency) compared to the third quarter of fiscal year 2011. Segment profit margin declined to 23.7% from 25.2% in the third quarter of fiscal year 2011. In the nine months, segment profit dollars were $233,191, an increase of $19,524, or 9.1% (approximately $14,500, or 7% in local currency) compared to the nine months of fiscal year 2011. Segment profit margin was 25.4% compared to 25.1% in the nine months of fiscal year 2011.

Segment profit dollars in the third quarter of fiscal year 2012 were $39,431, a decrease of $7,769, or 16.5% (approximately$7,500, or 16% in local currency). Segment profit margin decreased to 11.6% from 13.80% in the third quarter of fiscal year 2011. In the nine months, segment profit dollars were $131,195, a decrease of $3,061, or 2.3% (approximately$6,500, or 5% in local currency). Segment profit margin in the nine months decreased to 12.7% from 14.2% last year.

Read the The complete Report

About the author:

10qk
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 5.0/5 (1 vote)

Comments

Please leave your comment:


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK